Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Albumin Nanoparticle-Based Drug Delivery Systems
Na Qu, Ke Song, Yating Ji, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6945-6980
Open Access | Times Cited: 17

Showing 17 citing articles:

Biodegradable Polymeric Nanoparticle-Based Drug Delivery Systems: Comprehensive Overview, Perspectives and Challenges
Małgorzata Geszke-Moritz, Michał Moritz
Polymers (2024) Vol. 16, Iss. 17, pp. 2536-2536
Open Access | Times Cited: 23
New strategies for lung cancer diagnosis and treatment: applications and advances in nanotechnology
Jiaqi Feng, Pengpeng Zhang, Dingli Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
An Escin-loaded Glutaraldehyde-Albumin nanoparticle system for enhancing anticancer activity on lung cancer A549 cells
Murugan A. Munusamy, Muruganantham Bharathi, Abdurahman Hajinur Hirad, et al.
Results in Chemistry (2025), pp. 102021-102021
Open Access
An albumin-prodrug injectable formulation for synergistic cancer immunotherapy
Yang Li, Yuting Lu, Xiaoling Zhu, et al.
Journal of Colloid and Interface Science (2025) Vol. 686, pp. 1019-1032
Closed Access
Apoptosis and cell cycle arrest of bone marrow cells by green-synthesized silver but not albumin nanoparticles
Ehdaa Eldabousy, Lotfy Habbak, Ayman Hyder
Toxicology Reports (2025) Vol. 14, pp. 101960-101960
Open Access
Comprehensive Review on the Development of Phytonanomedicines for Cancer Treatment
Donald A. Fernandes
Deleted Journal (2025)
Closed Access
Advances in chemically modified HSA as a multifunctional carrier for transforming cancer therapy regimens
Zheng Sun, Hui Fu, Ruixuan Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 305, pp. 141373-141373
Closed Access
Glutaraldehyde-crosslinked Naringenin-loaded Albumin Nanoparticles (GNANPs) induce antimicrobial properties and apoptosis in gastric cancer cells
Murugan A. Munusamy, Muruganantham Bharathi, Abdullah A. Alarfaj, et al.
Toxicology in Vitro (2025), pp. 106037-106037
Closed Access
Multi-Pathway Study for Oxaliplatin Resistance Reduction
Tong Ye, Chen Wu, Jintong Na, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 172-172
Open Access
How Advanced Is Nanomedicine for Atherosclerosis?
Xiang Gu, Lixin Du, Ran Lin, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3445-3470
Open Access
Nanotechnology in Imatinib delivery: advancing cancer treatment through innovative nanoparticles
Azam Ghadami, Sonia Fathi‐karkan, Bazla Siddiqui, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Development and evaluation of nilotinib-loaded Bovine Serum Albumin nanoparticles: In-vitro and in-silico insights
Samia Shaikh, Padakanti Sandeep Chary, Omar M. Khan, et al.
International Journal of Biological Macromolecules (2025), pp. 142185-142185
Closed Access
Amplifying therapeutic potential through optimization of bioavailability of poorly soluble flavonols via albumin-based nanoparticles
Shayeri Chatterjee Ganguly, R. Maity, P. K. Manna, et al.
Drug Development and Industrial Pharmacy (2025), pp. 1-21
Closed Access
Recent Updates on Diverse Nanoparticles and Nanostructures in Therapeutic and Diagnostic Applications with Special Focus on Smart Protein Nanoparticles: A Review
M. Anju, Sarbari Acharya, Ravindra Kumar
ACS Omega (2024) Vol. 9, Iss. 42, pp. 42613-42629
Open Access | Times Cited: 1
Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer
Raquel Fernández-García, Ana Isabel Fraguas‐Sánchez
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1584-1584
Open Access | Times Cited: 1
Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
B. Durga, Ramachandran Vinayagam, Senthil Bakthavatchalam, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access
Bovine serum albumin nanoparticles: a promising platform for nasal drug delivery
Sandra Aulia Mardikasari, Gábor Katona, Ildikó Csóka
Expert Opinion on Drug Delivery (2024), pp. 1-4
Open Access
Page 1

Scroll to top